首页 > 用药指导 > 文章详情

Baricitinib(艾乐明)的用量是多少

发布时间:2023-12-11 09:13:18 阅读:1520 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉碧康制药股份有限公司 功能主治:对一种或多种抗风湿药物缓解不足或不耐受的中度至重 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(艾乐明)的用量是多少,Baricitinib(Baricitinib)治疗方式不同,用法不同,如:1、治疗类风湿性关节炎:推荐剂量为每日1次口服2mg,餐前餐后都可;2、治疗COVID-19病毒:推荐剂量为每日一次口服4mg,餐前餐后都可;3、治疗斑秃:推荐剂量是每天一次口服2mg,餐前餐后都可。

Baricitinib (brand name Olumiant) is a medication used for the treatment of rheumatoid arthritis, COVID-19, and alopecia areata. The dosage of Baricitinib depends on the specific medical condition being treated. It is important to note that dosage instructions for any medication should always be followed as prescribed by a healthcare professional. Therefore, the accurate dosage of Baricitinib for each condition should be determined and prescribed by a qualified healthcare provider.

1. Baricitinib Dosage for Rheumatoid Arthritis:

When prescribed for rheumatoid arthritis, the typical starting dose of Baricitinib is 2 milligrams (mg) once daily. This dosage can be taken with or without food. Depending on the individual response and tolerability, the dosage may be adjusted by a healthcare provider. The maximum recommended dosage for rheumatoid arthritis is 4 mg once daily.

2. Baricitinib Dosage for COVID-19:

During the COVID-19 pandemic, Baricitinib was investigated as a potential medication for the treatment of severe cases. The dosage used for COVID-19 treatment may differ from its regular use for rheumatoid arthritis. The specific dosage of Baricitinib for COVID-19 should be determined by a healthcare professional based on clinical guidelines and studies, as these may evolve over time. It is crucial to consult with a healthcare provider for the most up-to-date and accurate information regarding Baricitinib's use in COVID-19.

3. Baricitinib Dosage for Alopecia Areata:

Alopecia areata is an autoimmune condition that causes hair loss. Baricitinib has been studied as a potential treatment option for this condition. However, it is important to note that the use of Baricitinib for alopecia areata is still being investigated and its dosing regimen has not been firmly established. The dosage and duration of treatment for alopecia areata with Baricitinib should be determined by a healthcare professional specialized in dermatology or hair disorders.

In conclusion, the dosage of Baricitinib varies depending on the medical condition being treated. For rheumatoid arthritis, the starting dose is typically 2 mg once daily, with a maximum recommended dosage of 4 mg once daily. However, for COVID-19 and alopecia areata, the dosage should be determined by a qualified healthcare professional based on evolving guidelines and ongoing research. It is crucial to consult with a healthcare provider for accurate and up-to-date information regarding the proper dosage of Baricitinib for any specific medical condition.

孟加拉碧康制药股份有限公司碧康制药股份有限公司(Beacon,简称碧康制药)创建设于2001年,是孟加拉目前规模最大、技术最先进的抗肿瘤类和抗病毒类药物生产企业,也是该国成长最快的大型制药龙头企业。
直达企业主页

热门文章

更多